标题
Surrogacy Beyond Prognosis: The Importance of “Trial-Level” Surrogacy
作者
关键词
-
出版物
ONCOLOGIST
Volume 27, Issue 4, Pages 266-271
出版商
Oxford University Press (OUP)
发表日期
2022-01-09
DOI
10.1093/oncolo/oyac006
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Pathological response and survival with neoadjuvant therapy in melanoma: a pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC)
- (2021) Alexander M. Menzies et al. NATURE MEDICINE
- Disease-free survival as a surrogate for overall survival in patients with HER2-positive, early breast cancer in trials of adjuvant trastuzumab for up to 1 year: a systematic review and meta-analysis
- (2019) Everardo D Saad et al. LANCET ONCOLOGY
- Open science: The open clinical trials data journey
- (2019) Frank Rockhold et al. Clinical Trials
- Time Interval to Biochemical Failure as a Surrogate End Point in Locally Advanced Prostate Cancer: Analysis of Randomized Trial NRG/RTOG 9202
- (2018) James J. Dignam et al. JOURNAL OF CLINICAL ONCOLOGY
- Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer
- (2018) Gunter von Minckwitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Metastasis-Free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate Cancer
- (2017) Wanling Xie et al. JOURNAL OF CLINICAL ONCOLOGY
- Relapse-Free Survival as a Surrogate for Overall Survival in the Evaluation of Stage II–III Melanoma Adjuvant Therapy
- (2017) Stefan Suciu et al. JNCI-Journal of the National Cancer Institute
- Surrogate marker analysis in cancer clinical trials through time-to-event mediation techniques
- (2017) Sjouke Vandenberghe et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- Relapse-Free Survival as a Surrogate for Overall Survival in the Evaluation of Stage II–III Melanoma Adjuvant Therapy
- (2017) Stefan Suciu et al. JNCI-Journal of the National Cancer Institute
- Progression-free survival as surrogate end point for overall survival in clinical trials of HER2-targeted agents in HER2-positive metastatic breast cancer
- (2016) S. Michiels et al. ANNALS OF ONCOLOGY
- The Neoadjuvant Model Is Still the Future for Drug Development in Breast Cancer
- (2015) A. DeMichele et al. CLINICAL CANCER RESEARCH
- Individual Patient Data Analysis of Progression-Free Survival Versus Overall Survival As a First-Line End Point for Metastatic Colorectal Cancer in Modern Randomized Trials: Findings From the Analysis and Research in Cancers of the Digestive System Database
- (2015) Qian Shi et al. JOURNAL OF CLINICAL ONCOLOGY
- Surrogacy marker paradox measures in meta-analytic settings
- (2014) M. R. Elliott et al. BIOSTATISTICS
- Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
- (2014) Patricia Cortazar et al. LANCET
- Surrogate Measures and Consistent Surrogates
- (2013) Tyler J. VanderWeele BIOMETRICS
- Discussion on “Surrogate Measures and Consistent Surrogates”
- (2013) Judea Pearl BIOMETRICS
- Disease-Free Survival as a Surrogate for Overall Survival in Adjuvant Trials of Gastric Cancer: A Meta-Analysis
- (2013) Koji Oba et al. JNCI-Journal of the National Cancer Institute
- Progression-Free Survival as a Surrogate for Overall Survival in Advanced/Recurrent Gastric Cancer Trials: A Meta-Analysis
- (2013) Xavier Paoletti et al. JNCI-Journal of the National Cancer Institute
- Related Causal Frameworks for Surrogate Outcomes
- (2008) Marshall M. Joffe et al. BIOMETRICS
- Evaluation of Tumor Response, Disease Control, Progression-Free Survival, and Time to Progression As Potential Surrogate End Points in Metastatic Breast Cancer
- (2008) Tomasz Burzykowski et al. JOURNAL OF CLINICAL ONCOLOGY
- Preoperative Chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27
- (2008) Priya Rastogi et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now